n-heptane has been researched along with Depressive Disorder in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andreotti, D; Arban, R; Benedetti, R; Bertani, B; Bettati, M; Bettelini, L; Bonanomi, G; Braggio, S; Carletti, R; Cavanni, P; Checchia, A; Corsi, M; Di Fabio, R; Fazzolari, E; Fontana, S; Marchioro, C; Merlo-Pich, E; Micheli, F; Negri, M; Oliosi, B; Ratti, E; Read, KD; Roscic, M; Sartori, I; Spada, S; Tarsi, L; Tedesco, G; Terreni, S; Visentini, F; Zocchi, A; Zonzini, L | 1 |
1 other study(ies) available for n-heptane and Depressive Disorder
Article | Year |
---|---|
6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.
Topics: Animals; Antidepressive Agents; Azabicyclo Compounds; Brain; Depressive Disorder; Dopamine; Heptanes; Humans; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Microdialysis; Models, Molecular; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Structure-Activity Relationship | 2010 |